A mucoadhesive polymer with anti-SARS-COV-2 activity in vitro and in vivo

By | October 12, 2021
The team has evaluated a low molecular weight chitosan derivative as a candidate preventing the viral entry into mammalian nasal epithelial cells to limit the spread of COVID-19.